The CMA also notes that as of late December 2025, Health Canada had nine active applications from companies seeking to sell generic semaglutide [Source: cma.ca/healthcare-for-real/can-you-get-glp-1-drugs-canada]
In a statement to Fortune last month, Novo Nordisk said there was no mistake regarding its patent maintenance fee in Canada and declined to comment on other drug manufacturers plans
The most common are gastrointestinal, such as: nausea diarrhea vomiting reflux constipation Many of these symptoms resolve in time
[ref][ref] However, the lack of change in autonomic function due to a specific chemical may not be the right variable to control for
Addressing the most common misconceptions directly helps researchers make evidence-based decisions rather than fear-based ones
Side Effects Led More People to Stop Taking Orforglipron Than Its Rival Pill With both GLP-1 pills, the most common side effects were gastrointestinal issues such as nausea, diarrhea, vomiting, and indigestion, per Lilly
